
|Podcasts|September 26, 2022
Pharmacy Focus: Oncology Edition - Experts See Promising Future for the Treatment of Acute Lymphoblastic Leukemia
CAR T therapies are potentially revolutionizing the treatment of acute lymphoblastic leukemia (ALL).
Advertisement
This month, we spoke with Craig Freyer, PharmD, BCOP, clinical pharmacy specialist at Penn Medicine, to learn about how CAR T therapies are potentially revolutionizing the treatment of acute lymphoblastic leukemia (ALL). In addition to discussing what makes ALL treatment unique from other cancer treatments, Freyer said pharmacists have important roles to play in managing cytokine release syndrome and potential neuro-toxicities.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury
3
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
4
Balancing Survival and Quality of Life in Pancreatic Cancer: Expert Perspectives From an Immuneering Panel
5


























